Edgestream Partners L.P. boosted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 20.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 108,708 shares of the company's stock after buying an additional 18,682 shares during the quarter. Edgestream Partners L.P. owned approximately 0.12% of Acadia Healthcare worth $3,296,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. New York State Common Retirement Fund lifted its holdings in shares of Acadia Healthcare by 2.5% during the first quarter. New York State Common Retirement Fund now owns 232,582 shares of the company's stock worth $7,052,000 after purchasing an additional 5,775 shares during the period. Brown Advisory Inc. acquired a new position in shares of Acadia Healthcare in the 1st quarter valued at about $25,125,000. Envestnet Asset Management Inc. grew its stake in Acadia Healthcare by 8.2% during the first quarter. Envestnet Asset Management Inc. now owns 108,238 shares of the company's stock worth $3,282,000 after purchasing an additional 8,222 shares during the period. Palisade Capital Management LP increased its holdings in Acadia Healthcare by 2.1% in the first quarter. Palisade Capital Management LP now owns 613,332 shares of the company's stock worth $18,596,000 after purchasing an additional 12,807 shares in the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in Acadia Healthcare in the first quarter valued at approximately $412,000.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. Stephens upgraded Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Barclays reduced their price objective on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Guggenheim began coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price on the stock. Finally, Mizuho reduced their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.
Read Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Trading Down 3.7%
NASDAQ ACHC traded down $0.85 during trading on Friday, hitting $21.92. 1,278,458 shares of the company's stock traded hands, compared to its average volume of 1,870,740. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a fifty day moving average of $23.07 and a two-hundred day moving average of $30.14. The firm has a market cap of $2.02 billion, a P/E ratio of 10.80, a PEG ratio of 4.18 and a beta of 0.93. Acadia Healthcare Company, Inc. has a 12-month low of $20.36 and a 12-month high of $82.41.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. Acadia Healthcare's revenue for the quarter was up .3% on a year-over-year basis. During the same period in the prior year, the business posted $0.84 earnings per share. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.